Together, these findings suggest that plasma p-tau181 may provide better results in the diagnosis of SRC than total tau in the acute phase and that the combination of p-tau181 with GFAP, NFL, and UCH-L1 may potentially enhance the diagnostic accuracy of a multi-marker panel for mTBI/concussion. The gene discussed is MAPT; the disease is concussion.